MedTrace Logo

Self-assessment of Olfactory Disorders for French Speaking Patients

NCT04705805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2023-04-18

No results posted yet for this study

Summary

Sense of smell disorders are common and are said to affect up to 20% of the general population. They are often disabling and have a real impact on the quality of life. Smell disorders are most often assessed using a visual analogue scale and more rarely with objective tests (Sniffing Stick Test). Many ENT units do not have these objective tests because they are time-consuming and are not covered by health insurance.

Some teams, such as that of Dr Thomas Hummel of the Carl Gustav Carus University Clinic in Dresden Germany, have developed self-assessment questionnaires for the sense of smell in order to improve the overall care of patients with olfactory disorders. Two of these self-questionnaires seem to us to be particularly relevant for use in everyday practice.

Since then, these questionnaires have already been validated in different languages (English, Chinese, Korean...), but have never been translated and validated in French. Translating and validating these questionnaires into French would make it possible to improve the management and follow-up of French patients with olfactory disorders and to assess the impact of loss of smell on their quality of life.

Conditions

  • Post-viral Anosmia
  • Post-traumatic Anosmia
  • Chronic Rhinosinusitis
  • Idiopathic Anosmia
  • Age-related Loss of Smell

Interventions

BEHAVIORAL

Self-assessment of olfactory disorders through two questionnaires.

* Assessment of sense of smell or loss of smell using an Analogue Visual Scale * Carrying out the objective smell test (Sniffin' sticks test) (gold standard) * Information from two self-questionnaires translated into French: a quality of life questionnaire (The Questionnaire Olfactory Disorders (QOD)) and a self-assessment questionnaire of his olfactory capacities (Self-Mini Olfactory Questionnaire (Self-MOQ))

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-22
Primary Completion
2022-04-22
Completion
2022-04-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04705805 on ClinicalTrials.gov